Comparative Pharmacology
Head-to-head clinical analysis: DIURIL versus NATURETIN 2 5.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIURIL versus NATURETIN 2 5.
DIURIL vs NATURETIN-2.5
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inhibits sodium reabsorption in the distal convoluted tubule by blocking the sodium-chloride symporter, leading to increased excretion of sodium, chloride, and water.
Bendroflumethiazide is a thiazide diuretic that inhibits the sodium-chloride symporter (NCC) in the distal convoluted tubule of the kidney, reducing sodium and chloride reabsorption and promoting diuresis.
Adults: 500 mg to 1000 mg orally once or twice daily; maximum 2000 mg per day.
Hypertension: 2.5 mg orally once daily; may increase to 5 mg daily if needed. Edema: 2.5 to 10 mg orally once daily.
None Documented
None Documented
Terminal elimination half-life is 6-15 hours (mean 10 hours). In renal impairment, half-life can exceed 24 hours.
Terminal elimination half-life: 6-9 hours; prolonged in renal impairment and in elderly patients.
Primarily renal (90-95% excreted unchanged via glomerular filtration and tubular secretion); minimal biliary/fecal (<5%).
Renal excretion: approximately 95% as unchanged drug; biliary/fecal: <5%.
Category C
Category C
Thiazide Diuretic
Thiazide Diuretic